Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Trsg Stock Analysis Tungray Technologies Inc 1.55 Pct Gain 1.31 Price Outlook 20260403 1 What Technical Signals Show For Microvision Mvis Stock Price At 0.63 Up 4.86 20260408 What Is The Short Interest In L.B. Fstr Stock Fstr Q4 2025 Earnings L.B. Foster Company Misses Eps Estimates Widely 20260408 1 Daily Market Overview Nasdaq Outperforms As Three Major U.S. Indexes All Edge Higher 20260406 1 TrumpXi Summit Two Tech Flashpoints That Could Define the Outcome CapCity Bank CCBG Slips 176 Testing 4306 Support 20260515 EU Set to Revise Growth and Inflation Forecasts Amid Iran Conflict Stagflationary Shock US Hotel Owners Face Disappointing World Cup Demand as Survey Calls Tournament a NonEvent GLP1 Weight Loss Drugs Driving Up Prescription Costs CoPays Expected to Rise USIran Talks Show Progress but Key Disagreements Persist on Uranium Enrichment and Strait of Hormuz Tolls Rise in Solar Panel Purchases Driven by Energy Cost Savings Company Director Invests in 2000 Panels Nvidia Stock Approaches Critical Technical Level That Could Determine NearTerm Direction SpaceX Starship Faces Technical Challenges in Race for Lunar Mission Milestones Trump Seeks Supreme Court Intervention to Delay TikTok Ban SGMT Q1 2026 Earnings EPS Beat as Clinical Development Costs Tighten ATLCL Q1 2026 Earnings Strong EPS Beat Drives Modest Stock Gain ARTL Q4 2025 Earnings Narrowing Loss Surprises but Revenue Remains Absent ADCT Q1 2026 Earnings EPS Beat Amid Revenue Absence IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results GEHC Q1 2026 Earnings Profit Misses Estimates Amid Operational Headwinds Fidelity National Information Services FIS Slips Slightly as Stock Holds Near Key Support Douglas Elliman DOUG Dips Slightly Holds Above Key Support Amid Housing Market Uncertainty Propanc Biopharma PPCB Edges Lower Amid Biotech Volatility NovoCure NVCR Slumps 59 Testing Key Support at 1633 Aclaris Therapeutics ACRS Edges Lower Amid Tight Trading Range